[Daily Excelsior]Hetero’s Tocilizumab biosimilar gets emergency use authorisation from DCGI for COVID treatment
NEW DELHI, Sept 6: Drug firm Hetero on Monday said it has received emergency use authorisation from Drug Controller General of India (DCGI) for its biosimilar version of Tocilizumab for treatment of COVID-19 in hospitalised adults.The company will market the drug under the brand name ‘Tocira’, Hetero said in ...